secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0001437749-23-018566
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics appoints Mark Strobeck to Board and names Craig Fraser as Chair
--------------------------------------------------------------------------------

- Appointed Mark Strobeck, Ph.D. to the Board effective June 22, 2023; serves on Audit and Compensation Committees.
- Dr. Strobeck is President & CEO of Rockwell Medical; brings biotech/pharma management and M&A experience.
- Appointed Craig E. Fraser as Board Chair and Leslie J. Williams as Lead Independent Director, effective June 22, 2023.
- Strobeck receives annual cash retainer per non-employee director policy; initial equity grant under evaluation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774923018566/0001437749-23-018566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774923018566/wint20230626_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-018566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer